Concepedia

Liangpeng Yang

LY

Statistics

Publications

19

Citations

1K

H-Index

19

Active since

1976

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Shandong First Medical University

Shandong Tumor Hospital

Baylor College of Medicine

Koç University

Liangpeng Yang is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

1976–2023

19

Publications

19

NF-κB Hyper-Activation by HTLV-1 Tax Induces Cellular Senescence, but Can Be Alleviated by the Viral Anti-Sense Protein HBZ

Huijun Zhi, Liangpeng Yang, Yu-Liang Kuo et al. · PLoS Pathogens · 2011 · 127 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

Dawei Chen, Hampartsoum B. Barsoumian, Liangpeng Yang et al. · Cancer Immunology Research · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Dawei Chen, Hampartsoum B. Barsoumian, Grant M. Fischer et al. · Journal for ImmunoTherapy of Cancer · 2020 · 96 citations · Full text

Medicine, Oncology, Pharmacology +15

Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects

Yun Hu, Sébastien Paris, Hampartsoum B. Barsoumian et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 93 citations

Medicine, Oncology, Radiation Oncology +16

Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.

Li Li, Xinmin Liu, AB Glassman et al. · PubMed · 1997 · 69 citations

Life Sciences, Molecular Biology, Oncology +16

1–5 of 19